Search

everythinglearnresearchcommunity

for

Search:↓

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

GLP-1 agonists may increase the risk of hair loss.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Provenge extends prostate cancer survival by about 4 months.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

A specific RNA increases hair stem cell growth and skin healing by affecting a protein through interaction with a microRNA.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Upadacitinib effectively treats psoriasis and lichen planus together.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Erlotinib can cause excessive eyelash growth.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.